People · Operator
Named in public records as an officer, director or promoter · active 2017–2022 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Triana Biomedicines, Inc. | — | Pharmaceuticals | Series D+ | $178.6M | $852.8M | 2020 |
| Spero Therapeutics, Inc. | — | Biotechnology | Series C | $92.2M | $150.5M | 2017 |
| Avilar Therapeutics, Inc. | — | Pharmaceuticals | Series C | $75.3M | $2.3B | 2020 |
| Nayan Therapeutics, Inc. | — | Biotechnology | Seed | $3.0M | $133.2M | 2019 |
Milind Deshpande at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Milind Deshpande on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joshua Resnick | 3 | 12 |
| David Neafus | 2 | 7 |
| Jean-Francois Formela | 1 | 17 |
| ANDREW LEVIN | 1 | 17 |
| Scott Jackson | 1 | 13 |
| Shelley Chu | 1 | 10 |
| Christopher O'Donnell | 1 | 8 |
| David Grayzel | 1 | 6 |
| Vikas Goyal | 1 | 5 |
| Lorence Kim | 1 | 5 |
| Andrew Hedin | 1 | 5 |
| Paulina Hill | 1 | 5 |
| Casper Breum | 1 | 5 |
| ANKIT MAHADEVIA | 1 | 4 |
| Frank E. Thomas | 1 | 3 |
| Robert Millman | 1 | 3 |
| MARTIN FREED | 1 | 3 |
| DANIEL GRAU | 1 | 3 |
| Reza Halse | 1 | 3 |
| Jigar Raythatha | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.